Replies to post #10301 on DarioHealth Corp (DRIO)

[x1power]

Thanks for reply.

I never come out ahead on R/Splits, and you are right . . . we will just have to sit and wait for potential of FDA Approval PR.

DRIO now has to have a burn rate of roughly $1,00,000/month . . . if they are ramping up production? I am considering new R&D costs for future bodily fluids testing versions, also in the above burn rte estimate. You cannot employ over 12 employees,
rent, ship, and monitor foreign customer data in studies, advertise, and pay business taxes and materials and energy usage bills . . . much less than my monthly figure above.

My monthly burn rate guessimate can be all wet (or can it)?
Its got to cost at least $20 (and probably at this stage of testing device manufacture, over $60/device from an outside contractor. Asian sourcing is more and more becoming the way to go? Right now, doubtful DRIO has device manufacturing costs under $20 (materials fabrication and then hand assembly and testing).
What is your monthly burn rate calculation for DRIO business expenses? Anyone?

It is encouraging to think someone with business venture financing skills, put $4 Mil into DRIO. I do not think, as do you, that he is throwing his $$s away.


Next two quarters will tell the story on DRIO.
If they cannot get FDA USA Approval by March, 2015 . . . with all the foreign test subject data . . . DRIO is dreamscape vapour ware stock.

I sure do not want it to be . . . this medical innovation needs to happen, to benefit society and diabetics. Now we all get to sit and watch paint dry.

So far, DRIO are PR amateurs.
Any company that drops its retail investors into the dirt, is functionally inept.
Where are the governmental product support grants?

[sumotrader]

Any suggestion that FDA approval is imminent would be misguided IMO, every DRIO investor would be wise to research the FDA 510(K) approval process for the IbgStar device that was approved back in 2011. Only then will you understand why the 510(K) process is a). just a first step in the approval process and b). why it is so difficult to obtain with regards to ANY smart device.

Revenues from a highly saturated U.S. market are likely 9 months away and that is why I think new investor Edery will leverage his influence on the board and connections in South America to fast track renvenue growth.

This is not the slam dunk that some make it out to be IMO. All speculation on my part but I see no reason to "chase" or think DRIOD is going substantially North anytime soon.